Albers Jeffrey W. bought KYMR
June 24, 2026 · Form 4 insider transaction
Albers Jeffrey W. bought 6,068 shares of Kymera Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
6,068
Price
$0.00
Total value
N/A
InsiderAlbers Jeffrey W.
RoleDirector
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJune 24, 2026
Filing dateJune 25, 2026
Shares owned after6,068
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 24, 2027 and (ii) the date of the next annual meeting of the Issuer's stockholders.